Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials

Murielle Mimeault1, Surinder K Batra

  • 1Department of Biochemistry and Molecular Biology, College of Medicine, Eppley Cancer Institute, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA. mmimeault@unmc.edu

Drug Discovery Today
|August 21, 2012
PubMed

Insights

Zebrafish models offer a transparent in vivo system for studying cancer development and testing new drugs. These models aid in understanding cancer stem cells and evaluating treatments for aggressive cancers.

Area of Science:

  • Molecular oncology
  • Cancer research
  • Zebrafish models

Background:

  • In vivo zebrafish models are increasingly utilized in molecular oncology.
  • They facilitate the investigation of genetic alterations in human cancer development.
  • Zebrafish models serve as valuable tools for validating anticancer drug targets.

Purpose of the Study:

  • To highlight the utility of transparent zebrafish models in cancer research.
  • To demonstrate their application as a xenotransplantation system for cancer stem cells.
  • To showcase their role in testing novel anticancer agents and therapeutic strategies.

Main Methods:

  • Utilizing transparent zebrafish as an in vivo model.
  • Employing xenotransplantation assays to assess tumorigenicity and metastasis.
  • Evaluating novel anticancer agents and nanomaterials in vivo.

Main Results:

  • Zebrafish models enable rapid assessment of cancer stem cell tumorigenicity and metastasis.
  • They provide a platform for in vivo testing of anticancer drugs and nanomaterials.
  • These models help in evaluating treatments against aggressive and metastatic cancers.

Conclusions:

  • Zebrafish models are powerful tools for molecular oncology research.
  • They are effective for studying cancer development, metastasis, and drug efficacy.
  • Their application advances the development of novel cancer therapies.

Related Concept Videos